This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scholl, P. F. Articles by Wild, C. P. Search for Related Content PubMed PubMed Citation Articles by Scholl, P. F. Articles by Wild, C. P.

Quantitative Comparison of Aflatoxin B₁ Serum Albumin Adducts in Humans by Isotope Dilution Mass Spectrometry and ELISA

¹ Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland; ² Molecular Epidemiology Unit, Centre for Epidemiology and Biostatistics, Leeds Institute of Genetics, Health and Therapeutics, University of Leeds, Leeds, United Kingdom; and ³ Institut Pasteur de Guinée, Kindia, Republic of Guinea

Requests for reprints: Peter F. Scholl, Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205-2103. Phone: 410-955-4235; Fax: 410-955-0617. E-mail: pscholl{at}jhsph.edu.

Metabolic activation of the hepatocarcinogenic mycotoxin aflatoxin B₁ (AFB₁) results in the covalent attachment of AFB₁ to serum albumin. Digestion of adducted albumin releases AFB₁-lysine, a biomarker of exposure status. AF-albumin adducts have been most frequently measured in precipitated serum albumin using an immunoassay (ELISA); however, a sensitive and specific isotope dilution mass spectrometric (IDMS) assay for measurement of AFB₁-lysine in serum has recently been developed. The ELISA and IDMS methods were compared using 20 human sera collected in Guinea, West Africa, where AF exposure is endemic. Measurement of AFB₁-lysine adduct concentrations by IDMS in serum and albumin precipitated from the same sample revealed that precipitation has no effect on the measured adduct levels. The concentration of AF-albumin adducts measured by ELISA and AFB₁-lysine measured by IDMS in 2 mg of albumin were well correlated (R = 0.88, P < 0.0001); however, AF-albumin adduct concentrations measured by ELISA were on average 2.6-fold greater than those of the AFB₁-lysine adduct. Although these data suggest that the ELISA is measuring other AF adducts in addition to AFB₁-lysine, these biomarkers are comparable in their ability to assess AF exposure at AF-albumin concentrations 3 pg AFB₁-lysine equivalents/mg albumin. Identification of other adducts may clarify the mechanistic basis for using AF-protein biomarkers to assess exposure status in future epidemiologic studies of liver cancer. (Cancer Epidemiol Biomarkers Prev 2006;15(4):823–6)

This article has been cited by other articles:

				L. F. McCoy, P. F. Scholl, A. E. Sutcliffe, S. M. Kieszak, C. D. Powers, H. S. Rogers, Y. Y. Gong, J. D. Groopman, C. P. Wild, and R. L. Schleicher Human Aflatoxin Albumin Adducts Quantitatively Compared by ELISA, HPLC with Fluorescence Detection, and HPLC with Isotope Dilution Mass Spectrometry Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1653 - 1657. [Abstract] [Full Text] [PDF]

				P. F. Scholl and J. D. Groopman Long-term Stability of Human Aflatoxin B1 Albumin Adducts Assessed by Isotope Dilution Mass Spectrometry and High-Performance Liquid Chromatography-Fluorescence Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1436 - 1439. [Abstract] [Full Text] [PDF]

				L. Tang, M. Tang, L. Xu, H. Luo, T. Huang, J. Yu, L. Zhang, W. Gao, S. B. Cox, and J.-S. Wang Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention Carcinogenesis, February 1, 2008; 29(2): 411 - 417. [Abstract] [Full Text] [PDF]